DNA Nanoprobe Assists in Oral Tumor Navigation
Researchers developed a 10-nanometer DNA structure that enables real-time fluorescence imaging for surgical tumor removal.
Updated on Oct. 15, 2026 in Cancer
Live Poll
Do you believe new molecular imaging technologies will make cancer surgery more successful in your lifetime?
Scientists have engineered a tetrahedral DNA nanoprobe designed to improve surgical navigation and imaging of oral tumors. The study demonstrated that the probe facilitates fluorescence-guided tumor resection in mouse models.
Why it matters
The probe utilizes tetrahedral nanostructures to enhance biostability and cellular uptake while reducing steric hindrance within tumor tissue. This technology aims to provide surgeons with precise real-time guidance during delicate oral tumor removals.
The DNA nanoprobe measures approximately 10 nanometers in size and achieves fluorescence recovery between 43% and 72% after four hours. In vivo fluorescence analysis was conducted with a sample size of three mice.
The details
Constructed through thermal annealing, the probe employs a target-responsive fluorescence switch that releases a detection strand upon binding to specific tumor markers. This allows the probe to illuminate tumor tissue, providing clear boundaries for surgical navigation.
Timeline
10 minutes: Fluorescence signals appear following intravenous injection.
30 minutes: Fluorescence signals appear after local infiltration.
1 hour: In vitro signals reach 23 to 39 percent of maximum intensity.
20 hours: Intracellular fluorescence reaches its measured maximum.
2 weeks: Duration of the post-surgical follow-up period for mice.
The Big Picture
This development represents a significant shift in DNA nanotechnology-based cancer diagnostics by moving beyond passive sensing. It bridges the gap between molecular identification and real-time surgical application.
This research could eventually lead to more accurate surgical procedures for patients with oral and maxillofacial tumors. Future success in human trials may reduce the risk of incomplete tumor removal and the need for follow-up surgeries.
The takeaway
The successful use of a 10-nanometer DNA probe in animal models highlights the potential for nanoscale materials to improve surgical precision. Researchers are now focused on scaling these experiments to evaluate safety and clinical feasibility.
Further reading
Learn more about the latest innovations in Cancer research.
Source note: This article includes information reported by AZoNano.
Live Poll
Do you believe new molecular imaging technologies will make cancer surgery more successful in your lifetime?
